Indivior Pharmaceuticals (INDV) Shares Outstanding (2021 - 2026)

Indivior Pharmaceuticals' Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $24.8 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.0% year-over-year to $24.8 million in Q1 2026; TTM through Mar 2026 was $24.8 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $25.0 million, down 5.3% from the prior year.
• Shares Outstanding (Entity) retreated to $24.8 million in Q1 2026 per INDV's latest filing, from $25.0 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $27.8 million in Q4 2022 and bottomed at $24.8 million in Q1 2025.
• The 5-year median for Shares Outstanding (Entity) is $26.4 million (2024), against an average of $26.1 million.
• Across the five-year window, Shares Outstanding (Entity) slipped 8.82% in 2025 and changed 0.0% in 2026, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $27.8 million in 2022, then slipped by 1.44% to $27.4 million in 2023, then dropped by 3.65% to $26.4 million in 2024, then slipped by 5.3% to $25.0 million in 2025, then dropped by 0.8% to $24.8 million in 2026.
• Per Business Quant, the three latest INDV Shares Outstanding (Entity) figures stand at $24.8 million (Q1 2026), $25.0 million (Q4 2025), and $25.0 million (Q3 2025).